Schoretsanitis, Georgios

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2017 | 2016 | 2015

2017

Schoretsanitis, Georgios; Haen, Ekkehard; Stegmann, Benedikt; Hiemke, Christoph; Gründer, Gerhard; Paulzen, Michael (2017). Effect of smoking on risperidone pharmacokinetics – A multifactorial approach to better predict the influence on drug metabolism. Schizophrenia Research, 185, pp. 51-57. Elsevier 10.1016/j.schres.2016.12.016

Paulzen, Michael; Haen, Ekkehard; Stegmann, Benedikt; Unterecker, Stefan; Hiemke, Christoph; Gründer, Gerhard; Schoretsanitis, Georgios (2017). Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns. European archives of psychiatry and clinical neuroscience, 267(4), pp. 325-333. Springer 10.1007/s00406-016-0736-z

2016

Schoretsanitis, Georgios; Haen, Ekkehard; Gründer, Gerhard; Stegmann, Benedikt; Schruers, Koen; Hiemke, Christoph; Lammertz, Sarah; Paulzen, Michael (2016). Pharmacokinetic drug-drug interactions of mood stabilizers and risperidone in patients under Combined treatment. Journal of Clinical Psychopharmacology, 36(6), pp. 554-561. Lippincott Williams & Wilkins 10.1097/JCP.0000000000000601

Hovancakova, Jana; Schoretsanitis, Georgios; Grözinger, Michael; Gründer, Gerhard; Paulzen, Michael (2016). Interaction between risperidone, venlafaxine, and metronidazole: An unknown thread. Journal of Clinical Psychopharmacology, 36(6), pp. 730-733. Lippincott Williams & Wilkins 10.1097/JCP.0000000000000576

Schoretsanitis, Georgios; Eisenhardt, Sarah; Haen, Ekkehard; Lammertz, Sarah; Stegmann, Benedikt; Hiemke, Christoph; Gründer, Gerhard; Paulzen, Michael (November 2016). Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients (Unpublished). In: WPA International 2016 Congress Cape Town.

Chatzidiakou, Konstantinos; Schoretsanitis, Georgios; Schruers, Koen; Müller, Thomas; Ricklin, Meret; Exadaktylos, Aristomenis (2016). Acute psychiatric problems among migrants living in switzerland- a retrospective study from a swiss university emergency department. Emergency Medicine: Open Access, 6(5) Omics Publishing Group 10.4172/2165-7548.1000338

Schoretsanitis, Georgios; Stegmann, Benedikt; Hiemke, Christoph; Gründer, Gerhard; Schruers, Koen R J; Walther, Sebastian; Lammertz, Sarah E; Haen, Ekkehard; Paulzen, Michael (2016). Pharmacokinetic patterns of risperidone-associated adverse drug reactions. European journal of clinical pharmacology, 72(9), pp. 1091-1098. Springer 10.1007/s00228-016-2085-2

Paulzen, Michael; Haen, Ekkehard; Gründer, Gerhard; Lammertz, Sarah E; Stegmann, Benedikt; Schruers, Koen Rj; Walther, Sebastian; Schoretsanitis, Georgios (2016). Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions. Journal of psychopharmacology, 30(8), pp. 803-809. Sage Publications 10.1177/0269881116650390

Paulzen, Michael; Haen, Ekkehard; Stegmann, Benedikt; Hiemke, Christoph; Gründer, Gerhard; Lammertz, Sarah; Schoretsanitis, Georgios (2016). Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; A pharmacokinetics-based hypothesis. Psychoneuroendocrinology, 73, pp. 9-15. Elsevier 10.1016/j.psyneuen.2016.07.009

Schoretsanitis, Georgios; Haen, Ekkehard; Lammertz, Sarah; Stegmann, Benedikt; Hiemke, Christoph; Kuzin, Maxim; Gründer, Gerhard; Paulzen, Michael (June 2016). Pharmacokinetic considerations of different dosing regimens in clozapine medicated patient. Pharmacopsychiatry, 49(03). Thieme 10.1055/s-0036-1582042

Schoretsanitis, Georgios; Haen, Ekkehard; Lammertz, Sarah; Stegmann, Benedikt; Hiemke, Christoph; Veselinovic, Tania; Gründer, Gerhard; Paulzen, Michael (June 2016). Pharmacokinetic considerations in coprescription of perazine in risperidone medicated patients. Pharmacopsychiatry, 49(03). Thieme 10.1055/s-0036-1582041

Schoretsanitis, Georgios; Lammertz, Sarah; Hiemke, Christoph; Janssen, Ger; Gründer, Gerhard; Paulzen, Michael (June 2016). Effect of triglyceride and total cholesterol levels on the pharmacokinetics of clozapine in clozapine medicated patients. Pharmacopsychiatry, 49(03). Thieme 10.1055/s-0036-1582043

Kuzin, Maxim; Lammertz, Sarah; Stegmann, Benedikt; Haen, Ekkehard; Schoretsanitis, Georgios; Gründer, Gerhard; Paulzen, Michael (June 2016). Effects of proton pump inhibitors (PPI) on the metabolism of venlafaxine. Pharmacopsychiatry, 49(03). Thieme 10.1055/s-0036-1582053

Schoretsanitis, Georgios; Haen, Ekkehard; Hiemke, Christoph; Gründer, Gerhard; Stegmann, Benedikt; Schruers, Koen; Veselinovic, Tania; Lammertz, Sarah; Paulzen, Michael (2016). Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations? International clinical psychopharmacology, 31(5), pp. 259-264. Wolters Kluwer Lippincott Williams & Wilkins 10.1097/YIC.0000000000000131

Schoretsanitis, Georgios; Kutynia, Alexandra; Stegmayer, Katharina; Strik, Werner; Walther, Sebastian (2016). Keep at bay! - Abnormal personal space regulation as marker of paranoia in schizophrenia. European psychiatry, 31, pp. 1-7. Elsevier Masson SAS 10.1016/j.eurpsy.2015.10.001

2015

Schoretsanitis, Georgios; Kutynia, Alexandra; Strik, Werner; Walther, Sebastian (2015). Interpersonal distance regulation as marker of paranoia in schizophrenia. European archives of psychiatry and clinical neuroscience, 265(1), S124-S125. Springer

Schoretsanitis, Georgios; Kutynia, Alexandra; Strik, Werner; Walther, Sebastian (26 September 2015). Interpersonal distance regulation as marker of paranoia in schizophrenia (Unpublished). In: 5th European Conference on Schizophrenia Research. Berlin. 26.09.2015.

Provide Feedback